# FDA recall D-1424-2014

> **Hospira Inc.** · Class II · drug recall initiated 2014-05-16.

## Product

Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20

## Reason for recall

Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1424-2014
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-05-16
- **Report date:** 2014-07-16
- **Termination date:** 2017-03-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1424-2014

## Citation

> AI Analytics. FDA recall D-1424-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1424-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*